ACA Stock Analysis: Arcosa | NYSE
Engineering & Construction | NYSE, USA | Market Cap: 7.206m USD | 12M Return: 58.1% | US0396531008 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 102M
EPS Trend: 81.9%
Qual. Beats: 0
Rev. Trend: 95.5%
Qual. Beats: -2
Warnings
No concerns identified
Tailwinds
Seasonality 7.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Arcosa, Inc. (NYSE: ACA) is a U.S.-based provider of infrastructure-related products and solutions serving the construction, engineered structures, and transportation markets. The company operates through three reportable segments: Construction Products (natural and recycled aggregates, specialty materials, trench shields, and shoring products); Engineered Structures (utility, wind tower, traffic and lighting, and telecommunication structures); and Transportation Products (inland barges, fiberglass barge covers, winches, and marine hardware). Arcosa was incorporated in 2018 and is headquartered in Dallas, Texas, and trades as a mid-cap stock in the Industrials sector under the Construction & Engineering sub-industry classification.
The companys business model is tied closely to U.S. infrastructure spending cycles, with exposure to multiple end-markets including residential and non-residential construction, electricity transmission and distribution, wind power generation, highway construction, wireless communications, and commercial marine transportation. Its diversification across construction materials, structural products for energy and telecom infrastructure, and inland barge manufacturing provides multiple revenue streams tied to both public and private capital investment.
- Federal infrastructure spending lifts aggregates and structures demand
- Wind tower orders grow on renewable energy expansion
- Inland barge volumes track US grain export cycle
| Net Income: 491.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -3.32 > 1.0 |
| NWC/Revenue: 34.92% < 20% (prev 22.02%; Δ 12.90% < -1%) |
| CFO/TA 0.06 > 3% & CFO 341.3m > Net Income 491.4m |
| Net Debt (1.01b) to EBITDA (606.6m): 1.67 < 3 |
| Current Ratio: 3.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (49.2m) vs 12m ago 0.41% < -2% |
| Gross Margin: 23.04% > 18% (prev 20.82%; Δ 2.21% > 0.5%) |
| Asset Turnover: 53.23% > 50% (prev 53.39%; Δ -0.16% > 0%) |
| Interest Coverage Ratio: 3.31 > 6 (EBIT TTM 328.3m / Interest Expense TTM 99.1m) |
| A: 0.18 (Total Current Assets 1.41b - Total Current Liabilities 452.3m) / Total Assets 5.30b |
| B: 0.25 (Retained Earnings 1.31b / Total Assets 5.30b) |
| C: 0.06 (EBIT TTM 328.3m / Avg Total Assets 5.16b) |
| D: 1.29 (Book Value of Equity 2.98b / Total Liabilities 2.32b) |
| Altman-Z'' = 3.77 = AA |
| DSRI: 1.14 (Receivables 559.0m/477.0m, Revenue 2.74b/2.68b) |
| GMI: 0.90 (GM 20.82% / 23.04%) |
| AQI: 0.94 (AQ_t 0.34 / AQ_t-1 0.36) |
| SGI: 1.03 (Revenue 2.74b / 2.68b) |
| TATA: 0.03 (NI 491.4m - CFO 341.3m) / TA 5.30b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of October 09, 2026, the stock is trading at USD 146.50 with a total of 545,549 shares traded. Over the past week, the price has changed by +0.00%, over one month by +0.58%, over three months by +0.81% and over the past year by +58.06%.
Current recommended Stop Loss: 145.60 (which is 0.6% or 2 ATR below the current price).
Arcosa has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold ACA.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 146.7 | 0.1% |
P/E Trailing = 36.2346
P/E Forward = 29.8507
P/S = 2.4691
P/B = 2.4131
P/EG = 1.8642
Revenue TTM = 2.74b USD
EBIT TTM = 328.3m USD
EBITDA TTM = 606.6m USD
Long Term Debt = 1.43b USD (from longTermDebt, last quarter)
Short Term Debt = 7.70m USD (from shortTermDebt, last quarter)
Debt = 1.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.01b USD (calculated: Debt 1.44b - CCE 432.1m)
Enterprise Value = 8.22b USD (7.21b + Debt 1.44b - CCE 432.1m)
Interest Coverage Ratio = 3.31 (Ebit TTM 328.3m / Interest Expense TTM 99.1m)
EV/FCF = 60.79x (Enterprise Value 8.22b / FCF TTM 135.2m)
FCF Yield = 1.65% (FCF TTM 135.2m / Enterprise Value 8.22b)
FCF Margin = 4.93% (FCF TTM 135.2m / Revenue TTM 2.74b)
Net Margin = 17.90% (Net Income TTM 491.4m / Revenue TTM 2.74b)
Gross Margin = 23.04% ((Revenue TTM 2.74b - Cost of Revenue TTM 2.11b) / Revenue TTM)
Gross Margin QoQ = 23.64% (prev 21.15%)
Tobins Q-Ratio = 1.55 (Enterprise Value 8.22b / Total Assets 5.30b)
Interest Expense / Debt = 6.86% (Interest Expense 99.1m / Debt 1.44b)
Taxrate = 13.05% (29.9m / 229.2m)
NOPAT = 285.5m (EBIT 328.3m * (1 - 13.05%))
Current Ratio = 3.12 (Total Current Assets 1.41b / Total Current Liabilities 452.3m)
Debt / Equity = 0.48 (Debt 1.44b / totalStockholderEquity, last quarter 2.98b)
Debt / EBITDA = 1.67 (Net Debt 1.01b / EBITDA 606.6m)
Debt / FCF = 7.49 (Net Debt 1.01b / FCF TTM 135.2m)
Total Stockholder Equity = 2.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.53% (Net Income 491.4m / Total Assets 5.30b)
RoE = 18.16% (Net Income TTM 491.4m / Total Stockholder Equity 2.71b)
RoCE = 7.94% (EBIT 328.3m / Capital Employed (Equity 2.71b + L.T.Debt 1.43b))
RoIC = 6.05% (NOPAT 285.5m / Invested Capital 4.72b)
WACC = 9.19% (E(7.21b)/V(8.65b) * Re(9.84%) + D(1.44b)/V(8.65b) * Rd(6.86%) * (1-Tc(0.13)))
Discount Rate = 9.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 78.84 | Cagr: 0.27%
[DCF] Terminal Value 70.00% ; FCFF base≈198.8m ; Y1≈174.3m ; Y5≈140.9m
[DCF] Fair Price = 19.81 (EV 1.99b - Net Debt 1.01b = Equity 972.8m / Shares 49.1m; r=9.19% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 81.91 | EPS CAGR: 20.09% | SUE: -0.19 | # QB: 0
Revenue Correlation: 95.54 | Revenue CAGR: 9.54% | SUE: -1.09 | # QB: -2
EPS current Quarter (2026-09-30): EPS=1.58 | Chg30d=+0.96% | Revisions=+40% | Analysts=4
EPS current Year (2026-12-31): EPS=4.29 | Chg30d=-2.10% | Revisions=-40% | GrowthEPS=-4.0% | GrowthRev=-10.2%
EPS next Year (2027-12-31): EPS=5.12 | Chg30d=+0.69% | Revisions=+40% | GrowthEPS=+19.3% | GrowthRev=+9.7%
[Analyst] Revisions Ratio: +22% (up=4, down=2)